UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1926
Grid Dynamics Holdings
GDYN
$632M
| $1.27M | ﹤0.01% |
165,342
-66,761
| -29% | -$596K |
2021 Q3
16 quarters
|
|
1927
Core Laboratories
CLB
$459M
| $1.27M | ﹤0.01% |
103,100
-62,545
| -38% | -$733K |
2013 Q2
49 quarters
|
|
1928
AMERISAFE
AMSF
$463M
| $1.27M | ﹤0.01% |
29,056
-30,298
| -51% | -$1.36M |
2017 Q1
34 quarters
|
|
1929
PDF Solutions
PDFS
$1.69B
| $1.26M | ﹤0.01% |
48,964
-36,647
| -43% | -$800K |
2017 Q2
33 quarters
|
|
1930
Optimum Communications Inc
OPTU
$353M
| $1.26M | ﹤0.01% |
524,235
-312,008
| -37% | -$765K |
2018 Q4
27 quarters
|
|
1931
Invesco Mortgage Capital
IVR
$604M
| $1.26M | ﹤0.01% |
166,910
-143,351
| -46% | -$1.09M |
2023 Q1
10 quarters
|
|
1932
PC Connection
CNXN
$2.27B
| $1.26M | ﹤0.01% |
20,324
-15,078
| -43% | -$962K |
2021 Q1
18 quarters
|
|
1933
Praxis Precision Medicines
PRAX
$6.85B
| $1.26M | ﹤0.01% |
23,756
-73,189
| -75% | -$3.55M |
2024 Q2
5 quarters
|
|
1934
N-able
NABL
$844M
| $1.24M | ﹤0.01% |
159,542
-93,742
| -37% | -$751K |
2023 Q1
10 quarters
|
|
1935
Heritage Financial
HFWA
$1.12B
| $1.24M | ﹤0.01% |
51,365
-47,369
| -48% | -$1.15M |
2015 Q3
40 quarters
|
|
1936
Sable Offshore Corp
SOC
$649M
| $1.24M | ﹤0.01% |
71,134
-41,876
| -37% | -$1.07M |
2024 Q2
5 quarters
|
|
1937
DELISTED
Apogee Therapeutics
APGE
| $1.24M | ﹤0.01% |
31,163
-23,899
| -43% | -$913K |
2024 Q2
5 quarters
|
|
1938
Sturm, Ruger & Co
RGR
$681M
| $1.24M | ﹤0.01% |
28,471
-24,252
| -46% | -$874K |
2013 Q2
49 quarters
|
|
1939
DELISTED
Cidara Therapeutics
CDTX
| $1.24M | ﹤0.01% |
+12,900
| New | +$823K |
2025 Q3
0 quarters
|
|
1940
Porch Group
PRCH
$1.97B
| $1.23M | ﹤0.01% |
73,300
+52,938
| +260% | +$812K |
2025 Q2
1 quarter
|
|
1941
MiMedx Group
MDXG
$667M
| $1.23M | ﹤0.01% |
176,094
-144,668
| -45% | -$1.01M |
2023 Q1
10 quarters
|
|
1942
Amprius Technologies
AMPX
$1.16B
| $1.23M | ﹤0.01% |
+116,484
| New | +$916K |
2025 Q3
0 quarters
|
|
1943
ThredUp
TDUP
$301M
| $1.22M | ﹤0.01% |
129,307
+107,844
| +502% | +$1.02M |
2025 Q2
1 quarter
|
|
1944
Harmony Gold Mining
HMY
$10.7B
| $1.22M | ﹤0.01% |
+67,184
| New | +$1.01M |
2025 Q3
0 quarters
|
|
1945
Malibu Boats
MBUU
$444M
| $1.22M | ﹤0.01% |
37,474
-35,187
| -48% | -$1.2M |
2023 Q1
10 quarters
|
|
1946
Red Cat Holdings
RCAT
$727M
| $1.22M | ﹤0.01% |
+117,484
| New | +$1.1M |
2025 Q3
0 quarters
|
|
1947
Horizon Bancorp
HBNC
$997M
| $1.21M | ﹤0.01% |
75,512
-58,100
| -43% | -$930K |
2023 Q1
10 quarters
|
|
1948
First Financial Corp
THFF
$880M
| $1.2M | ﹤0.01% |
21,337
-14,323
| -40% | -$811K |
2020 Q2
21 quarters
|
|
1949
Arcus Biosciences
RCUS
$2.79B
| $1.19M | ﹤0.01% |
87,771
-85,827
| -49% | -$892K |
2020 Q2
21 quarters
|
|
1950
Center Bancorp
CNOB
$1.53B
| $1.18M | ﹤0.01% |
47,737
-58,314
| -55% | -$1.44M |
2018 Q1
30 quarters
|
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.